The need and challenges for development of vaccines against emerging infectious diseases.

Sue Ann Costa Clemens, Ralf Clemens
Author Information
  1. Sue Ann Costa Clemens: Department of Pediatrics, Oxford University, Oxford, United Kingdom; Institute for Global Health, University of Siena, Siena, Italy.
  2. Ralf Clemens: International Vaccine Institute (IVI), Seoul, South Korea. Electronic address: clemens.ralf@outlook.com.

Abstract

OBJECTIVE: To identify and describe learnings from past pandemics and to suggest a framework for vaccine development as part of epi/pandemic readiness.
SOURCE OF DATA: Articles/ reviews/letters on pandemic preparedness/ vaccines published between 2005 and 2022 in PubMed, MEDLINE, MedRxiv, BioRxiv, Research Square, Gates Open Research; who.int, cepi.net, visualcapitalist.com, airfinity.com, ted.com websites; press releases.
SUMMARY OF FINDINGS: Disease pandemics caused by emerging pathogens impacted the social development, health and wealth of most societies in human history. In an outbreak, the first months determine its course. To block an exponential spread and the development of an epi/ pandemic early, vaccine availability in sufficient quantities is of paramount importance. It is inevitable that new human viruses will emerge. Any future pandemic will come likely from RNA viruses through zoonotic or vector transmission, but we cannot predict when or where "Disease X" will strike. Public health, scientific and societal readiness plans need to include: continuous identification of new viruses in common mammalian reservoir hosts; continuous epidemiological surveillance, including wastewater sampling; establishment of prototype vaccine libraries against various virus families sharing functional and structural properties; testing of various and innovative vaccine platforms including mRNA, vector, nasal or oral vaccines for suitability by virus family; functional clinical trial sites and laboratory networks in various geographies; more efficient phasing of preclinical and clinical activities; global harmonization and streamlining of regulatory requirements including pre-established protocols; and societal preparedness including combating any pandemic of misinformation.
CONCLUSIONS: "Outbreaks are unavoidable, pandemics are optional".

Keywords

References

  1. J Glob Health. 2022 May 23;12:05020 [PMID: 35604879]
  2. Lancet. 2017 Feb 4;389(10068):505-518 [PMID: 28017403]
  3. Nat Med. 2022 Jul;28(7):1330-1331 [PMID: 35641823]
  4. N Engl J Med. 2022 Aug 4;387(5):470-472 [PMID: 35921459]
  5. Science. 2018 Feb 23;359(6378):872-874 [PMID: 29472471]
  6. Science. 2022 Aug 26;377(6609):960-966 [PMID: 35881005]
  7. N Engl J Med. 2022 Jul 14;387(2):e3 [PMID: 35249271]
  8. Nat Med. 2022 Jul;28(7):1325 [PMID: 35864253]
  9. J Clin Invest. 2020 Jul 1;130(7):3348-3349 [PMID: 32352406]
  10. Med Hist Suppl. 2008;(27):74-100 [PMID: 18575083]
  11. N Engl J Med. 2015 Jul 23;373(4):297-300 [PMID: 26200974]
  12. J Infect Dis. 2018 Nov 22;218(suppl_5):S698-S704 [PMID: 30321368]
  13. Lancet Infect Dis. 2020 Oct;20(10):1193-1203 [PMID: 32497524]
  14. JAMA. 2021 Jul 27;326(4):303-304 [PMID: 34236382]
  15. Nat Immunol. 2018 Jan;19(1):20-28 [PMID: 29199281]
  16. PLoS Pathog. 2020 Sep 3;16(9):e1008758 [PMID: 32881980]
  17. Lancet Infect Dis. 2022 Sep;22(9):1293-1302 [PMID: 35753318]
  18. Lancet Microbe. 2022 Jan;3(1):e11-e20 [PMID: 34751259]
  19. Nature. 2023 Jan;613(7943):340-344 [PMID: 36384167]
  20. Sci Rep. 2015 Oct 07;5:14830 [PMID: 26445169]
  21. Science. 2022 Aug 26;377(6609):951-959 [PMID: 35881010]
  22. Am J Med. 2021 Feb;134(2):176-181 [PMID: 32979306]
  23. Nature. 2017 Jan 18;541(7638):444-445 [PMID: 28128262]
  24. Lancet Infect Dis. 2019 Sep;19(9):1013-1022 [PMID: 31351922]
  25. Lancet. 2022 Apr 16;399(10334):1513-1536 [PMID: 35279232]
  26. Nature. 2022 Sep;609(7925):101-108 [PMID: 35798029]
  27. Lancet. 2015 Nov 28;386(10009):2204-21 [PMID: 26615326]
  28. J Infect Dis. 2007 Nov 15;196 Suppl 2:S131-5 [PMID: 17940940]

MeSH Term

Animals
Humans
Communicable Diseases, Emerging
Vaccines
Disease Outbreaks
Pandemics
Mammals

Chemicals

Vaccines

Word Cloud

Created with Highcharts 10.0.0vaccinedevelopmentpandemicincludingpandemicsvaccinescomviruseswillvariousreadinessOFResearchemergingpathogenshealthhumannewvectorsocietalneedcontinuousvirusfunctionalclinicalOBJECTIVE:identifydescribelearningspastsuggestframeworkpartepi/pandemicSOURCEDATA:Articles/reviews/letterspreparedness/published20052022PubMedMEDLINEMedRxivBioRxivSquareGatesOpenwhointcepinetvisualcapitalistairfinitytedwebsitespressreleasesSUMMARYFINDINGS:Diseasecausedimpactedsocialwealthsocietieshistoryoutbreakfirstmonthsdeterminecourseblockexponentialspreadepi/earlyavailabilitysufficientquantitiesparamountimportanceinevitableemergefuturecomelikelyRNAzoonotictransmissionpredict"DiseaseX"strikePublicscientificplansinclude:identificationcommonmammalianreservoirhostsepidemiologicalsurveillancewastewatersamplingestablishmentprototypelibrariesfamiliessharingstructuralpropertiestestinginnovativeplatformsmRNAnasaloralsuitabilityfamilytrialsiteslaboratorynetworksgeographiesefficientphasingpreclinicalactivitiesglobalharmonizationstreamliningregulatoryrequirementspre-establishedprotocolspreparednesscombatingmisinformationCONCLUSIONS:"Outbreaksunavoidableoptional"challengesinfectiousdiseasesCEPICovid-19EmergingPandemicsVaccines

Similar Articles

Cited By